154 related articles for article (PubMed ID: 15302230)
1. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
5. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well.
Gullulu M; Akdag I; Kahvecioglu S; Filiz G; Savci V
Ren Fail; 2006; 28(6):509-14. PubMed ID: 16928621
[TBL] [Abstract][Full Text] [Related]
7. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
[TBL] [Abstract][Full Text] [Related]
9. Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats.
Veliotes DG; Norton GR; Correia RJ; Strijdom H; Badenhorst D; Brooksbank R; Woodiwiss AJ
J Cardiovasc Pharmacol; 2010 Aug; 56(2):203-11. PubMed ID: 20531215
[TBL] [Abstract][Full Text] [Related]
10. Influence of Valsartan on myocardial apoptosis in spontaneously hypertensive rats.
Li W; Sun N; Liu W; Chen Y; Yu Y
Chin Med J (Engl); 2002 Mar; 115(3):364-6. PubMed ID: 11940365
[TBL] [Abstract][Full Text] [Related]
11. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
Naruse M; Tanabe A; Sato A; Takagi S; Tsuchiya K; Imaki T; Takano K
Hypertension; 2002 Jul; 40(1):28-33. PubMed ID: 12105134
[TBL] [Abstract][Full Text] [Related]
13. Role of the renin-angiotensin-aldosterone system in collecting duct-derived endothelin-1 regulation of blood pressure.
Ge Y; Huang Y; Kohan DE
Can J Physiol Pharmacol; 2008 Jun; 86(6):329-36. PubMed ID: 18516095
[TBL] [Abstract][Full Text] [Related]
14. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
16. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
de Resende MM; Kriegel AJ; Greene AS
J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
[TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
